Published online
doi:10.1084/jem.20080588
The Journal of Experimental Medicine, Vol. 205, No. 8, 1755-1761
The Rockefeller University Press, 0022-1007 $30.00
© Takahashi et al.
IL-17 produced by Paneth cells drives TNF-induced shock
Nozomi Takahashi1,
Ineke Vanlaere3,4,
Riet de Rycke3,4,
Anje Cauwels3,4,
Leo A.B Joosten1,2,
Erik Lubberts1,5,
Wim B. van den Berg1, and
Claude Libert3,4
1 Rheumatology Research and Advanced Therapeutics and 2 Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, Netherlands
3 Department for Molecular Biomedical Research, VIB, B9052 Ghent, Belgium
4 Department of Molecular Biology, Ghent University, B9052 Ghent, Belgium
5 Department of Rheumatology, Erasmus Medical Center, 3015 GE Rotterdam, Netherlands
CORRESPONDENCE Claude Libert: Claude.Libert{at}UGent.be
Tumor necrosis factor (TNF) has very potent antitumor activity, but it also provokes a systemic inflammatory response syndrome that leads to shock, organ failure, and death. Here, we demonstrate that interleukin (IL)-17, a proinflammatory cytokine known to be produced mainly by activated T cells, has a critical role in this process. Antiserum against IL-17 or deletion of Il17r protected mice against a lethal TNF challenge. Serum levels of TNF-induced IL-6 and nitric oxide metabolites were significantly reduced in mice deficient in the IL-17R. TNF-induced leukocyte influx in the small intestine was reduced, and there was no injury to the small intestine. Surprisingly, electron microscopy showed that IL-17 was constitutively present in Paneth cells of the crypts. Upon TNF challenge, the intracellular pool of IL-17 in these cells was drastically reduced, suggesting rapid release of IL-17 from the granules of Paneth cells. Our findings assign a novel role for IL-17 in an acute inflammation and identify Paneth cells as a source of the IL-17 that plays a role in this process. These data indicate that innate immune cytokine responses in the local mucosa may participate in rapidly amplifying responses to systemic inflammatory challenges.
N. Takahashi and I. Vanlaere contributed equally to this paper.
© 2008 Takahashi et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., Yoshimura, A., Tedgui, A., Mallat, Z.
(2009). Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. JEM
206: 2067-2077
[Abstract]
[Full Text]
-
Huys, L., Van Hauwermeiren, F., Dejager, L., Dejonckheere, E., Lienenklaus, S., Weiss, S., Leclercq, G., Libert, C.
(2009). Type I interferon drives tumor necrosis factor-induced lethal shock. JEM
206: 1873-1882
[Abstract]
[Full Text]
-
Zhang, X., Gao, L., Lei, L., Zhong, Y., Dube, P., Berton, M. T., Arulanandam, B., Zhang, J., Zhong, G.
(2009). A MyD88-Dependent Early IL-17 Production Protects Mice against Airway Infection with the Obligate Intracellular Pathogen Chlamydia muridarum. J. Immunol.
183: 1291-1300
[Abstract]
[Full Text]
-
Freitas, A., Alves-Filho, J. C., Victoni, T., Secher, T., Lemos, H. P., Sonego, F., Cunha, F. Q., Ryffel, B.
(2009). IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis. J. Immunol.
182: 7846-7854
[Abstract]
[Full Text]
-
Maitra, U., Davis, S., Reilly, C. M., Li, L.
(2009). Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-1. J. Immunol.
182: 5763-5769
[Abstract]
[Full Text]
-
Joshi, A. D., Fong, D. J., Oak, S. R., Trujillo, G., Flaherty, K. R., Martinez, F. J., Hogaboam, C. M.
(2009). Interleukin-17-mediated Immunopathogenesis in Experimental Hypersensitivity Pneumonitis. Am. J. Respir. Crit. Care Med.
179: 705-716
[Abstract]
[Full Text]